A randomized, double-blind, placebo-controlled, three arm study to evaluate the effects of tolterodine ER [extended release] 4 mg vs. placebo vs. oxybutynin ER on memory and other cognitive abilities in elderly subjects.
Phase of Trial: Phase IV
Latest Information Update: 06 Jul 2007
At a glance
- Drugs Oxybutynin; Tolterodine
- Indications Overactive bladder
- Focus Pharmacodynamics
- Sponsors Pfizer
- 06 Jul 2007 Status change from recruiting to completed
- 05 Jan 2007 New trial record.